Wednesday, July 8, 2026

pharma · Primary Mitochondrial Myopathy · Advanced Solid Tumors, Advanced Breast Cancer · OKUR

OnKure Therapeutics

OnKure Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Boulder, USA HQ
2011 Founded
42 Employees
Public company Type
OKUR · NYSE Ticker
Company details
Status
Public
HQ
Boulder, USA
Founded
2011
Employees
42
Programs
8
Drugs
4
Patents
7
Intelligence · Clinical Programs

OnKure Therapeutics projects

1 ClinicalTrials.gov programs sponsored by OnKure Therapeutics.

OnKure Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. REN001

    OnKure Therapeutics

    Primary Mitochondrial Myopathy

    phase 3 small molecule terminated

    2 trials

Frequently asked questions

How many clinical projects does OnKure Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.